# A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.

> **NCT02923791** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 256 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** Filgrastim Hospira
- **BIOLOGICAL:** US-Approved Neupogen

## Key facts

- **NCT ID:** NCT02923791
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02923791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02923791, "A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02923791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*